EC says timeline to mark risky drugs is practical

03/11/2013 | In-PharmaTechnologist.com

The European Commission says it is giving companies ample time to avoid supply disruptions while they identify certain high-risk drugs with a mandatory inverted black triangle. In general, drug companies have nine months to implement the new labeling requirements for currently marketed products, although the EC will allow more time in individual cases. Existing inventory does not need to be re-labeled.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY